HIF1A and cancer: As described above, HIF-1α is a key regulator of the cellular hypoxia response and is a popular target for drug development, especially in cancer therapeutics, as hypoxia is a key feature of the tumor microenvironment that is leveraged by cancer cells to induce angiogenesis, activate proliferation, and adjust metabolism [209,210,211,212,213].